Amikacin and Cephalothin: Empiric Regimen for Granulocytopenic Cancer Patients

Amikacin (15 mg/kg per day) was used in combination with cephalothin (7 g/m(2) per day) as an empiric regimen for de novo febrile (>101°F [38.3°C]) episodes in 93 granulocytopenic (<1,000/mm(3)) cancer patients. Both drugs were given intravenously in four equal doses every 6 h. The response rate for...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Hahn, Davis M., Schimpff, Stephen C, Young, Viola Mae, Fortner, Clarence L., Standiford, Harold C., Wiernik, Peter H.
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1977
Assuntos:	Pharmacology and Therapeutics
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC429987/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/335967/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.12.5.618
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!